No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: No mention of efficacy again...
1
Mar 27, 2019 01:04PM
6
Mar 29, 2019 01:05PM
2
Mar 29, 2019 02:01PM

Buckeyes, where do you stand?

Do you agree with Bear, that there is a reasonable argument for a $5-$7 billion valuation at this point in time if this is what you are stating?

"$5-$7 billion would be a reasonable offer right now, pre-top-line, with the buying big pharma assuming the risk of BETonMACE failure."

 

Koo

4
Mar 29, 2019 07:25PM
2
Mar 29, 2019 07:59PM
4
bfw
Mar 29, 2019 09:04PM
2
Mar 29, 2019 09:07PM
2
Mar 29, 2019 09:27PM
Share
New Message
Please login to post a reply